We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protein Has Key Role in Muscle Cell Fusion

By Biotechdaily staff writers
Posted on 16 Apr 2007
Scientists have discovered that a protein called WIP (WASp-interacting protein; WASp is the Wiskott-Aldrich Syndrome protein), which attaches to the internal part of the myoblast recognition protein, plays a key role in muscle cell fusion. More...
This finding may help in designing new methods for healing injured and diseased muscle tissue using stem cells.

Muscle fibers are large cells that contain many nuclei. They begin, like all animal cells, as naïve embryonic cells. These cells differentiate, producing intermediate cells called myoblasts that are destined to become muscle. New myoblasts then seek out other myoblasts, and when they find each other, they stick together. In the final stage of muscle fiber development, the cell membranes of attached myoblasts open up and fuse together, forming one large, unified cell.

How myoblasts identify other myoblasts and how they cling together had been established, but the way that the cell membranes fuse into one has remained a mystery. A study by scientists from the Weizmann Institute (Rehovot, Israel) has shed light on this mystery. The cells' system for identifying other myoblasts and sticking to them consists of protein molecules that poke through the outer cell membrane--one end pointing out and the other extending into the body of the cell.

The protein, (WIP), communicates between the recognition protein and the cell's internal skeleton, which is made of tough, elastic fibers composed of a protein called actin. The skeletal actin applies force to the abutting cell membranes, opening and enlarging holes that allow the cells to merge. The Weizmann Institute team found that the WIP protein is activated by an external signal once myoblasts identify and attach to each other. Only when it receives this signal does WIP hook the actin fibers in the skeleton up to the myoblast recognition protein, allowing cell fusion to proceed.

The WIP protein has been conserved evolutionarily. Versions of it exist in all animals, from microorganisms such as yeast, through worms and flies, and up to humans. This means that the protein fulfills a function necessary for life but also, say the scientists, because of this conservation, studies conducted on this protein in fruit flies can teach us quite a bit about how it works in humans.

To further examine the role of WIP, the scientists knocked out the gene responsible for producing it in fruit flies. In flies that did not make the protein, normal muscle fibers were not produced. WIP-deficient myoblasts continued to identify and cozy up to one another, but fusion between cell membranes did not take place, and multi-nucleated muscle fibers failed to form.

An article describing these findings appeared in the April 2007 issue of the journal Developmental Cell. Dr. Eyal Schejter, Prof. Ben-Zion Shilo, and colleagues of the Weizmann Institute's molecular genetics department and Dr. Vera Shinder from the electron microscopy unit participated in this research.

This study, which improves an understanding of the process of muscle formation, may assist in devising new and advanced methods for healing muscle. Specifically, these might include ways of fusing stem cells with injured or degenerated muscle fibers.

Fusion between cell membranes plays a key role in development of different kinds of bone cells, placental cells, and immune system cells, as well as in fertilization and in the penetration of viruses into living cells. Understanding how membrane fusion takes place may one day lead to the development of ways to encourage the process when it's needed or hinder it when it's likely to cause harm.


Related Links:
Weizmann Institute

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.